June 30, 2026 (COPENHAGEN, Denmark). Zerion Pharma A/S (“ZERION”) today announces the completion of a combined royalty financing and equity investment (the “Transaction”) with Ligand Pharmaceuticals, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results